본문 바로가기

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
Scopus Q2
저널
ONCOTARGET6(29) · pp.26746 · 2015
피인용
Web of Science 57
JCR IF
JCR 2014 6.359
ISSN
1949-2553

저자

  1. Kim, Hyun-Soo제1저자연세대학교, Coll Med, Dept Pathol, KO
  2. 윤건부산대학교, 부산대학교병원, 대학병원, KO
  3. Ryu, Ji-Yoon성균관대학교, Sch Med, Samsung Med Ctr, KO
  4. Cho, Young-Jae성균관대학교, Sch Med, Samsung Med Ctr, KO
  5. Choi, Jung-Joo성균관대학교, Sch Med, Samsung Med Ctr, KO
  6. Lee, Yoo-Young성균관대학교, Sch Med, Samsung Med Ctr, KO
  7. Kim, Tae-Joong성균관대학교, Sch Med, Samsung Med Ctr, KO
  8. Choi, Chel-Hun성균관대학교, Sch Med, Samsung Med Ctr, KO
  9. Song, Sang Yong성균관대학교, Sch Med, Samsung Med Ctr, KO
  10. Kim, Byoung-Gie성균관대학교, Sch Med, Samsung Med Ctr, KO
  11. Bae, Duk-Soo성균관대학교, Sch Med, Samsung Med Ctr, KO
  12. Lee, Jeong-Won교신저자성균관대학교, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, KO

초록

Sphingosine kinase 1 (SPHK1), an oncogenic kinase, has previously been found to be upregulated in various types of human malignancy and to play a crucial role in tumor development and progression. Although SPHK1 has gained increasing prominence as an important enzyme in cancer biology, its potential as a predictive biomarker and a therapeutic target in cervical cancer remains unknown. SPHK1 expression was examined in 287 formalin-fixed, paraffin-embedded cervical cancer tissues using immunohistochemistry, and its clinical implications and prognostic significance were analyzed. Cervical cancer cell lines including HeLa and SiHa were treated with the SPHK inhibitors SKI-II or FTY720, and effects on cell survival, apoptosis, angiogenesis, and invasion were examined. Moreover, the effects of FTY720 on tumor growth were evaluated using a patient-derived xenograft (PDX) model of cervical cancer. Immunohistochemical analysis revealed that expression of SPHK1 was significantly increased in cervical cancer compared with normal tissues. SPHK1 expression was significantly associated with tumor size, invasion depth, FIGO stage, lymph node metastasis, and lymphovascular invasion. Patients with high SPHK1 expression had lower overall survival and recurrence-free survival rates than those with low expression. Treatment with SPHK inhibitors significantly reduced viability and increased apoptosis in cervical cancer cells. Furthermore, FTY720 significantly decreased in vivo tumor weight in the PDX model of cervical cancer. We provide the first convincing evidence that SPHK1 is involved in tumor development and progression of cervical cancer. Our data suggest that SPHK1 might be a potential prognostic marker and therapeutic target for the treatment of cervical cancer.

키워드

Pathology Sectionsphingosine kinase 1cervical cancerprogressionprognosisFTY720SPHINGOLIPID METABOLISMOVARIAN-CARCINOMAPOOR SURVIVALPROGRESSIONEXPRESSIONCHEMOTHERAPYSPHK1OVEREXPRESSIONPROLIFERATION1-PHOSPHATE

식별자

WoS UID
000363161300024